Fosaprepitant
- Product NDC
- 25021-784
- 11-digit product format
- 250210784
- Labeler code
- 25021
- Product ID
- 25021-784_51f1d99a-b729-4254-bafd-a808fdff1a44
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosaprepitant Dimeglumine
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA204845
- Marketing category
- ANDA
- Marketing start
- 2019-12-15
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Neurokinin 1 Antagonists [MoA],Substance P/Neurokinin-1 Receptor Antagonist [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A4 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 25021-784-10 | 25021078410 | 1 VIAL in 1 CARTON (25021-784-10) > 5 mL in 1 VIAL | 1 vial | 2019-12-15 | 0000-00-00 | No | No | Current |